These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1223580)

  • 1. [Changes of the platelet aggregation in patients with chronic renal insufficiency under extracorporeal dialysis].
    Grgicević D; Antos M; Pistotnik M; Prejac M; Flego I
    Lijec Vjesn; 1975 Oct; 97(9):509-12. PubMed ID: 1223580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in platelet aggregation in patients on a chronic intermittent dialysis program].
    Malý J; Erben J; Pecka M; Jebavý L; Bláha M; Siroký O
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(3-4):295-306. PubMed ID: 6985168
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet aggregation before and after hemodialysis in chronic renal insufficiency.
    Kageyama T; Oyabu H; Tsumoto S; Kimoto S; Toda H
    Bull Osaka Med Sch; 1983 Oct; 29(2):62-8. PubMed ID: 6680327
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of ultrafiltrates in plasma from patients with chronic uremia on platelet aggregation].
    Myśliwiec M; Popławski A; Soszka J
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):76-8. PubMed ID: 1845699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelet aggregation in chronic renal failure].
    Sánchez Casajús A; Lasierra J; Viladés E
    Rev Clin Esp; 1979 Apr; 153(2):137-41. PubMed ID: 482679
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathophysiology of platelet anomalies and its analysis. (3). Platelet aggregation, with special reference to clinical evaluation of the platelet aggregation in patients with diabetes mellitus and those under chronic hemodialysis].
    Matsuo T
    Rinsho Byori; 1983 Nov; 31(11):1168-75. PubMed ID: 6672292
    [No Abstract]   [Full Text] [Related]  

  • 7. [High circulating prostacyclin levels in patients with chronic renal insufficiency (author's transl)].
    Carreras LO; Chamone DA; Vermylen J
    Sangre (Barc); 1981; 26(4):427-32. PubMed ID: 7027492
    [No Abstract]   [Full Text] [Related]  

  • 8. [Criteria of the evaluation of the aggregative capacity of thrombocytes in patients with chronic renal failure during hemodialysis].
    Rud'ko IA; Kubatiev AA; Kulakov GP
    Urol Nefrol (Mosk); 1988; (3):48-53. PubMed ID: 3218007
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of vitamin E on platelet function and anemia in patients on long-term hemodialysis].
    Janicka L; Dmoszyńska A; Ksiazek A; Kozioł M
    Pol Tyg Lek; 1988 Nov; 43(48):1557-8. PubMed ID: 3255907
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation between products of fibrin degradation and platelet dysfunction in chronic renal failure. Effects of aspirin].
    Lazzari MA; Pavlovsky M; Martínez Canaveri A
    Medicina (B Aires); 1977; 37(2):97-105. PubMed ID: 895494
    [No Abstract]   [Full Text] [Related]  

  • 11. [Platelet aggregation in patients with chronic renal insufficiency not under dialytic treatment].
    Camici M; Evangelisti L; Balestri PL
    Minerva Nefrol; 1981; 28(4):467-70. PubMed ID: 7339515
    [No Abstract]   [Full Text] [Related]  

  • 12. [Assessment of haemostasis in fifteen uraemic patients subjected to chronic haemodialysis (author's transl)].
    Barrantes Boulanger A; Soto Quirós M; Salas González R
    Sangre (Barc); 1980; 25(3):289-99. PubMed ID: 7414445
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of recombinant human erythropoietin on thrombocyte aggregation capacity and on the blood prostanoid level in patients with chronic kidney failure on hemodialysis].
    Rud'ko IA; Pokrovskiĭ IuA; Ermolenko VM; Kubatiev AA
    Ter Arkh; 1991; 63(10):128-30. PubMed ID: 1805410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kinetics of leukocytes during hemodialysis].
    Wolf A; Stummvoll HK; Pinggera WF; Oppolzer R
    Wien Med Wochenschr; 1976 Oct; 126(41):595-7. PubMed ID: 63186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Personal experience with the administration of sulfinpyrazone to patients with kidney failure].
    Opatrný K; Cepelák V; Opatrný K; Valenta J; Cepeláková H; Sefrna F
    Vnitr Lek; 1986 Jul; 32(7):673-80. PubMed ID: 3526712
    [No Abstract]   [Full Text] [Related]  

  • 16. "In vitro" inhibition of platelet aggregation by uremic middle molecules.
    Gallice P; Fournier N; Crevat A; Saingra S; Frayssinet R; Murisasco A; Sicardi F
    Biomedicine; 1980; 33(6):185-8. PubMed ID: 7213919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propyl gallate-induced platelet aggregation in patients with end-stage renal disease: the influence of the haemodialysis procedure.
    Eleftheriadis T; Antoniadi G; Liakopoulos V; Tsiandoulas A; Barboutis K; Stefanidis I
    Nephrology (Carlton); 2006 Feb; 11(1):3-8. PubMed ID: 16509924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Picotamide, selective inhibitor of thromboxane synthesis in patients on maintenance hemodialysis.
    Vandelli L; Grosoli M; Lusvarghi E; Cenci AM; Campioli D; Grossi G
    Nephrol Dial Transplant; 1989; 4(12):1083-4. PubMed ID: 2517331
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of plasma coagulatiion and blood platelet function in patients with kidney insufficiency and their modification through homodialysis, kidney transplantation and acetylsalicylic acid].
    Vonend E; Böttcher D; Knödler U; Heinze V
    Med Welt; 1974 Jan; 25(3):91-8. PubMed ID: 4592049
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electroencephalographic changes in patients with extracorporeal dialysis for renal insufficiency].
    Hernández Peniche J; Silva Mendoza H; Corro Ayusso R
    Prensa Med Mex; 1972; 37(9):326-30. PubMed ID: 4662596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.